i Screening and Natural History

Similar documents
HCV Epidemiology, Screening, Natural History, and Extra-Hepatic Manifestations

Navigating The Prior Authorization Approval Process. Kristin Webb, RPCA University at Buffalo

Navigating The Prior Authorization Approval Process

Hepatitis C in Dr. Michael Bays D.O.

Epidemiology and Screening for Hepatitis C Infection

Hepatitis C in Disclosures

THE CHANGING LANDSCAPE OF HEPATITIS INFECTION. Michael E. Herman D.O.

Digestive & Liver Disease Wellness

Strategies to Address HCV

26/09/2014. Types of Viral Hepatitis. Prevention of Viral Hepatitis as a Health Disparity for American Indians: Successes and Challenges

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

HEPATITIS C : RECENT ADVANCES IN SCREENING & MANAGEMENT

Zobair M. Younossi M.D., M.P.H., FACG

HCV in the Latino Community -Epidemiology, Natural History, Risk Factors, Screening and Diagnosis

C 肝職業暴露後之處置 衛福部疾病管制署 中區傳染病防治醫療網 王任賢指揮官

Assessing the patient with a new diagnosis of Hepatitis C LAUREN MYERS MMSC, PA-C OREGON HEALTH & SCIENCE UNIVERSITY

Hepatitis C. No disclosures. 1. The USPSTF recommends Hepatitis C screening in which patient populations?

Commonly Asked Questions About Chronic Hepatitis C

NIH Consensus Conference Statement. Management of Hepatitis C. March 24-26, NIH Web site. Available at:

Numbers HCV and HIV Epidemiology in the US

Pennsylvania Academy of Family Physicians Foundation & UPMC 43rd Refresher Course in Family Medicine CME Conference March 10 13, 2016

THIS ACTIVITY HAS EXPIRED. CME CREDIT IS NO LONGER AVAILABLE

WHEN HCV TREATMENT IS DEFERRED WV HEPC ECHO PROJECT

Viral Hepatitis. Dr Melissa Haines Gastroenterologist Waikato Hospital

STOP Hepatocellular Carcinoma

Hepatitis STARS Program. Geri Brown, M.D. Associate Professor Department of Internal Medicine October 4, 2003

4/8/16. Learning Objectives. Overview Hepatitis C. What IS Hepatitis C?? Overview Hepatitis C

Updates in the Treatment of Hepatitis C

Arvind R. Murali, MD Assistant Professor of Medicine Gastroenterology & Hepatology Organ Transplant Center UIHC, Carver College of Medicine

ORAL MANIFESTATIONS IN LIVER DISEASES

Management of Hepatitis C in Primary Care BABAFEMI ONABANJO, MD & BEN ALFRED, FNP UMASS FAMILY HEALTH CENTER WORCESTER

Worldwide Causes of HCC

Overview of Hepatitis C Virus: The Challenge & The Opportunity. Cody A. Chastain, MD

Definition: Active injection drug users - Those who have injected any drug(s) within the 12 month reporting period

@PremierHA #AdvisorLive. Download today s slides at

Worldwide Causes of HCC

HEPATITIS C. Whitney Dickson, PharmD, BCPS October 12 th, 2017

Hepatitis C. David Byers, MD, FACP Senior Medical Director for Infectious Diseases and Wound Healing Services Southern Ohio Medical Center

The Long Term Care Risk

Hepatitis C in Massachusetts Michael Gaucher and Shauna Onofrey MA Department of Public Health Bureau of Infectious Disease & Laboratory Sciences

Hepatitis C in Correctional Facilities: Big Problem, Bigger Opportunity. Cody A. Chastain, MD

Brief Review of HIV and Hepatitis C Virus (HCV) Infection (with focus on HCV)

Initial Evaluation for HCV Therapy. Hope McGratty PA-C, MPH

Objectives. Five Take Home Pearls. We Can Cure Hepatitis C. Hepatitis C Screening, Treatment and the Family Physician 10/15/2018

HCV: Racial Disparities. Charles D. Howell, M.D., A.G.A.F Professor of Medicine University of Maryland School of Medicine Baltimore, MD

ABCs of Viral Hepatitis What Primary Care Physicians Need to Know

Hepatitis C Management and Treatment

New York State HCV Provider Webinar Series. HCV Medication Prior Authorization

DISCLOSURES. This activity is jointly provided by Northwest Portland Area Indian Health Board and Cardea

Viral hepatitis and Hepatocellular Carcinoma

Hepatitis C COLVILLE FOCUSED DIAGNOSIS, MANAGEMENT, TREATMENT

S401- Updates in the Treatments of Hepatitis B & C

Hepatitis. Epidemiology and Prevention of Viral Hepatitis A, B, and C:

Hepatitis C Screening For Baby Boomers in Primary Care. Nicole Mesick DO, RD NHAFP Conference May 18 th, 2018

Treatment of Patients with HCV and HIV

Update on Hepatitis B and Hepatitis C

Lifetime risk of infection >60% Early childhood infections common

Uses and Misuses of Viral Hepatitis Testing. Origins of Liver Science

Chronic viral hepatitis and liver disease in Belgium Pierre Deltenre

Hepatitis C: Newest Treatment Options and What To Do When We Cure It!

This is an AbbVie sponsored educational webinar which is being presented

Primary Care Approach to Diagnosis and Management of Chronic Hepatitis C Brian Viviano, D.O.

MONTE TROUTMAN, DO, FACOI, FAME UNTHSC/TCOM ASSOCIATE PROFESSOR OF MEDICINE OBJECTIVES

Hepatitis C Virus (HCV)

The Dawn of a New Era: Hepatitis C

Hepatitis A, B, and Mostly C

Hepatitis is an epidemic disease that can be caused by different viruses including hepatitis viruses A, B, C, D or E.

Prevent Hepatocellular Carcinoma through Screening, Vaccination, and Treatment of Viral Hepatitis Milena Gould Suarez, MD

Disclosure. Objectives. Hepatitis C: A silent and potentially deadly but curable epidemic

Corporate Medical Policy

ADDRESSING VIRAL HEPATITIS IN PEOPLE WITH SUBSTANCE USE DISORDERS: A THREE (3) PART SERIES

EVALUATION OF ABNORMAL LIVER TESTS

End Stage Liver Disease & Disease Specific Indications for Liver Transplant. Susan Kang, RN, MSN, ANP-BC

End Stage Liver Disease & Disease Specific Indications for Liver Transplant Susan Kang, RN, MSN, ANP BC

Agenda. Hepatitis C: Evaluation & Treatment. Background. Natural History of Hepatitis C. Epidemiology 9/23/2014

Increasing Hepatitis C Knowledge for Behavioral Health and Medical Providers

HCV Treat now! Robert G Gish MD. Professor Consultant Stanford University

HEPATITIS C, ACUTE CRUDE DATA. Number of Cases 5 Annual Incidence a LA County 0.05 California b 0.10 United States b 0.68 Age at Diagnosis Mean 38

Welcome to A Chronic Disease You Can Cure: Hepatitis C Treatment for Primary Care Providers Conference February 24, 2018

Outline. Updates in the Clinical Management of Hepatitis B and C. Who should be screened for HBV? Chronic Hepatitis B 10/7/2018

New York State HCV Provider Webinar Series

Hepatitis C. Core slides

The ABCs of Viral Hepatitis Diagnosis. Ila Singh, M.D., Ph.D. P & S Viral Hepatitis. Hepatitis A, B, C, D, E and G viruses

Hepatitis C Policy Discussion

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

HCV care after cure. This program is supported by educational grants from

Hepadnaviridae family (DNA) Numerous antigenic components Humans are only known host May retain infectivity for more than 7 days at room temperature

Hepatitis C in the United States : Preparing for the Test and Cure Era

Viral Hepatitis - Historical Perspective

A Practical Guide to Hepatitis C Management

Disclosures 2/20/2015 TREATMENT OF HEPATITIS C: 2015 UPDATE. Epidemiology and Natural History of HCV Infection

Replaces: 04/14/16. Formulated: 8/2007 HEPATITIS C POLICY

ACTIVITY DISCLAIMER. Kurt Cook, MD, MSc DISCLOSURE. Audience Engagement System. Learning Objectives

Recommendations for Hepatitis C Screening

Hepatitis C Infection: Updated Information for Front Line Workers in Primary Care Settings MAMTA K. JAIN, MD, MPH 2/14/18

Geo-epidemiology of Hepatitis C in Northeast Indiana

Bruce A. Luxon, MD, PhD, FACG Consultant: Vertex Speakers Bureau: Merck

hepatitis C MEDICAL INFORMATION UPDATE transmission diagnosis clinical management treatment

Improving Access & Linkage to Care in Underserved Populations & Baby Boomers

UNIVERSAL SCREENING FOR HCV

Transcription:

HCV Epidemiology, i Screening and Natural History BRUCE A. LUXON, MD, PHD, FACG ANTON AND MARGARET FUISZ CHAIR IN MEDICINE PROFESSOR AND CHAIRMAN DEPARTMENT OF MEDICINE GEORGETOWN UNIVERSITY Hepatitis C In the U.S. Why Should You Care? 5.1 million estimated true prevalence 3.9 million CDC estimate Large reservoir of infected patients who are undiagnosed Incarcerated Homeless Nursing homes Hospitalized Active Military 25% Diagnosed And Untreated http://ww.cdc.gov/hepatitis/statistics/index.htm Chak E, et al. Liv Int 2011;31:1090-1101 Copyright 2015 American College of Gastroenterology 1

Theme for Today: Goats Typical DC teenager With fashion goat Natural History of HCV Acute Infection* Chronic Infection 75%-85% Cirrhosis 10%-20% over 20 years HCC 1%-4% per year Decompensated Cirrhosis 5-yr survival rate 50% Asymptomatic *Most have minimal symptoms Most Americans infected >35y Additional impact of: Alcohol Obesity Older age Copyright 2015 American College of Gastroenterology 2

Consequences of Under-Diagnosis of HCV Infection 33% of undiagnosed Americans have advanced fibrosis/cirrhosis Now Job Security McGarry LJ, et al. Hepatology 2012;55:1344-1355 Davis G, et al. Gastroenterology 2010;138(2):513-521. A Bipartisan View of Life in DC Another DC teenager with her special goat Copyright 2015 American College of Gastroenterology 3

HCV is a Systemic Disease Acute Infection* Chronic Infection 75%-85% Cirrhosis 10%-20% over 20 years HCC 1%-4% per year Decompensated Cirrhosis 5-yr survival rate 50% Extra hepatic Manifestations Extrahepatic Manifestations of HCV Strongly associated Mixed cryoglobulinemia Sjögren (sicca) syndrome Lymphoproliferative disorders Porphyria cutanea tarda Neuropathy Membranoproliferative glomerulonephritis Cryoglobulinemic vasculitis Possibly associated Corneal ulcers (Mooren ulcers) Thyroid disease Lichen planus Pulmonary fibrosis Type 2 diabetes Systemic vasculitis (polyarteritis nodosa, microscopic polyangiitis) Arthralgias, myalgias, inflammatory polyarthritis Autoimmune thrombocytopenia Adapted from Ali A, Zein NN. Cleve Clin J Med. 2005;72:1005-1008. Copyright 2015 American College of Gastroenterology 4

HCV Infection Increases Risk of Chronic Kidney Disease REVEAL-HCV Study HCV (+), High VL HCV (+), Low VL HCV (-) N=23,785; 1,313 seropositive for HCV Lai TS, et al. AASLD 2014, Abstract #172 HCV Infection is Associated with Increased All Cause Mortality Reveal-C tive Mortality (%) Cumula Anti-HCV+, HCV RNA detectable Anti-HCV ( ) 23,800 adults, 16.2 y f/u All Causes Liver Cancer Extrahepatic ti Diseases (n=2394) (n=115) (n=2199) 35 12 20 19.8%* 30 30.1%* 18 10.4%* 10 16 25 14 8 12.2% 12 20 11.0% 6 10 15 12.8% 8 10 12.4% 4 6 5 2 1.6% 4 2 0 0 0.3% 0 0 2 4 6 8 10 12 14 16 18 20 0 2 4 6 8 10 12 14 16 18 20 0 2 4 6 8 10 12 14 16 18 20 Follow-Up (Years) Follow-Up (Years) Follow-Up (Years) Lee M-H, et al. J Infect Dis 2012;206:469-477 Copyright 2015 American College of Gastroenterology 5

Increasing Healthcare Costs Associated with the Aging HCV Population ) Prevalence (Million Prevalence (95% CI) Health Care Cost (95% CI) Razavi H, et al. Hepatology 2013;57:2164-2170 Expensive to have end stage liver disease We Can Make A Difference! 30 All-Cause Mortality 20 Percent 10 Non-SVR P<.001 SVR 0 0 1 2 3 4 5 6 7 8 9 10 Time (years) Van der Meer AJ, et al. JAMA 2012;308:2584-2593 Copyright 2015 American College of Gastroenterology 6

How to Distinguish Yourself Be a Trendsetter Screen for HCV and refer to specialist How to Distinguish Yourself Be a Trendsetter Beware of copycats.ahhh copy goats. well you know what I mean Copyright 2015 American College of Gastroenterology 7

Goat Humor: a Jar Jar Binks Lookalike from Iowa How Do You Get Hepatitis C? Copyright 2015 American College of Gastroenterology 8

1998 CDC Risk Based HCV Screening Recommendations Ever injected illegal drugs Received blood, organs, or clotting factors prior to 1992 Have ever been on hemodialysis Have elevated ALT Born to HCV infected mothers Have HIV infection Percutaneous or mucosal exposure to HCV positive blood CDC. MMWR 1998;47(RR-19):1-39 Risk-Based Screening Does Not Work Primary care setting, U.S. 2005-2010 17,464 tested for HCV 6.4% positive Odds ratios for positive anti-hcv IVDU: 6.3 1945-1965 birth cohort: 4.4 Elevated ALT: 4.8 Risk based screening missed 4 out of 5 HCV positive adults Yartel AK, et al. AASLD 2013; abstract #24 Copyright 2015 American College of Gastroenterology 9

HCV in the US 2001-2010 Milliman Study: Based on NHANES and Claim Forms 82% aged 44-63 years http://publications.milliman.com/research/health-rr/pdf/consequences-hepatitis-c-virus-rr05-18-09.pdf HCV in the U.S. 8,810 Americans with hepatitis C infection Danville PA, Detroit MI, Portland OR, Honolulu HI 50% Distribution by Birth Year 45% 40% 35% 30% 42% 33.30% 75% born between 1945-19641964 25% 20% 15% 10% 5% 0% 7.20% 8.20% 4.60% 1.40% 1935-1944 1945-1954 1955-1964 1965-1974 1975-1984 1985-1990 Moorman AC, et al. CID 2013;56:40-50 Copyright 2015 American College of Gastroenterology 10

Bruce A. Luxon, MD, PhD, FACG Baby Boomer Epidemic Anti-HCV Prevalence byy Birth Year, NHANES 1999-2008 Smith BD, et al. AASLD 2011, abstract 241 Birth Year 1945 1965 Baby Boomers Woodstock Festival 1969 Share Love and Hep C Copyright 2015 American College of Gastroenterology 11

Not Only the Boomer s Fault Hepatitis C was not on the radar Blood supply was contaminated No universal precautions in healthcare settings No way to screen organs or blood products 2012 CDC Recommendations for Birth Cohort Screening (1945-1965) Recommendation #1 Adults born from 1945-1965 should receive one-time testing for HCV. Recommendation #2 HCV (+) individuals Brief alcohol screening and intervention Referral to appropriate care for HCV Smith BD, et al. Ann Intern Med 2012;157;817-822 Copyright 2015 American College of Gastroenterology 12

2013 USPSTF HCV Screening Recommendations 1. Those at high risk for HCV infection 2. Those born from 1945 to 1965 Grade B recommendation high certainty that the net benefit is moderate to substantial The Affordable Care Act Requires insurance plans to provide Grade A or B recommendations without cost sharing USPSTF = United States Preventive Services Task Force Moyer VA - on behalf of the USPSTF. Ann Intern Med 2013;159:349-357 Is it Effective? 3 Randomized Controlled Trials Compared to standard of care Testing for HCV in persons born 1945-1965 with no prior testing Was 5 times more effective in identifying persons with current or prior infection Smith BD, et al. AASLD 2014, Abstract #194 Copyright 2015 American College of Gastroenterology 13

For Non-Baby Boomers Risk based screening IVDU single or multiple Intranasal cocaine use Getting an unregulated tattoo and other percutaneous exposures Blood or blood product transfusion before 1992 Born to an HCV-infected mother Incarceration Moyer VA - on behalf of the USPSTF. Ann Intern Med 2013;159:349-357 Transmission of HCV Route IV drug use Transfusion Hemodialysis Intra-institutional Sexual Household Mother-to-newborn Oral-oral contact Food-borne Fecal (oral) Water-borne Raw shellfish Hepatitis C Generates Questions in my Clinic Common Infrequent Never Copyright 2015 American College of Gastroenterology 14

HCV Is Not Going Away! You Want Your Doctor to Avoid These Mistakes Liver tests are normal, not much can be going on. Hepatitis i C does not damage the liver unless alcohol l is involved. I discussed vaccinating patient vs. HCV & patient declined. There is nothing to do about treating hepatitis C. Treatment of hepatitis C is worse than the disease. Copyright 2015 American College of Gastroenterology 15

3,500 3,000 Number of cases 2,500 2,000 1,500 1,000 500 0 Year Source: National Notifiable Diseases Surveillance System (NNDSS) HISTOLOGIC STAGING NO FIBROSIS STAGE 0 STAGE 1 PORTAL FIBROSIS STAGE 2 FEW SEPTA STAGE 3 NUMEROUS SEPTA CIRRHOSIS STAGE 4 STOP Before Here Copyright 2015 American College of Gastroenterology 16

Importance of Confirming Viremia Anti-HCV Antibody Positive HCV RNA HCV Genotype Positive Consider Liver Biopsy Vaccinate for HAV / HBV* Negative Negative No Further Testing No Active Disease This is Not Magic Why Diagnose? Copyright 2015 American College of Gastroenterology 17

Benefits of Diagnosis PREVENT TRANSMISSION Avoid sharing objects with blood Stop illicit drugs or sharing needles Discuss risk of sexual transmission with unsafe sex OTHER RECOMMENDATIONS Avoid alcohol consumption Discuss available treatments Vaccinate for hepatitis A and B Test for HBV, HIV Consider family member screening I Know It Sounds Unbelievable -- It Will Only Get Better Copyright 2015 American College of Gastroenterology 18

I Know It Sounds Unbelievable It Will Only Get Better HCV Epidemiology, Screening and Natural History - Summary 1. Most HCV patients remain undiagnosed 2. 75% of them were born from 1945-1965 3. 33% of them have advanced fibrosis ticking time bombs waiting to explode (bleed) on a Friday at midnight when you are on call 4. Therapy is more effective and safer 5. It s time to incorporate screening into your practice! Copyright 2015 American College of Gastroenterology 19

Thank You Copyright 2015 American College of Gastroenterology 20